These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31620963)

  • 1. Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis.
    Houshmand F; Barati M; Golab F; Ramezani-Sefidar S; Tanbakooie S; Tabatabaei M; Amiri M; Sanadgol N
    Daru; 2019 Dec; 27(2):583-592. PubMed ID: 31620963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK/Nrf2/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period.
    Sanadgol N; Barati M; Houshmand F; Hassani S; Clarner T; Shahlaei M; Golab F
    Pharmacol Rep; 2020 Jun; 72(3):641-658. PubMed ID: 32048246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
    Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
    Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12/IL-17/IL-11 axis and restriction of mature oligodendrocytes apoptosis.
    Sanadgol N; Golab F; Tashakkor Z; Taki N; Moradi Kouchi S; Mostafaie A; Mehdizadeh M; Abdollahi M; Taghizadeh G; Sharifzadeh M
    Pharm Biol; 2017 Dec; 55(1):1679-1687. PubMed ID: 28447514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model.
    Largani SHH; Borhani-Haghighi M; Pasbakhsh P; Mahabadi VP; Nekoonam S; Shiri E; Kashani IR; Zendehdel A
    J Mol Histol; 2019 Jun; 50(3):263-271. PubMed ID: 31016544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome.
    Ammar RA; Mohamed AF; Kamal MM; Safar MM; Abdelkader NF
    Inflammopharmacology; 2022 Jun; 30(3):919-934. PubMed ID: 35364735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
    Salinas Tejedor L; Gudi V; Kucman V; Pul R; Gingele S; Sühs KW; Stangel M; Skripuletz T
    Histol Histopathol; 2015 Dec; 30(12):1455-64. PubMed ID: 26110560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation.
    Elbaz EM; Senousy MA; El-Tanbouly DM; Sayed RH
    Toxicol Appl Pharmacol; 2018 Aug; 352():153-161. PubMed ID: 29864483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cordycepin (3'-deoxyadenosine) promotes remyelination via suppression of neuroinflammation in a cuprizone-induced mouse model of demyelination.
    Jia Y; Li H; Bao H; Zhang D; Feng L; Xiao Y; Zhu K; Hou Y; Luo S; Zhang Y; Xiao L; Chen X; Zhou J; Wang C; Wang G; Yu H; Xiao C; Du J
    Int Immunopharmacol; 2019 Oct; 75():105777. PubMed ID: 31357085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
    Ghaiad HR; Nooh MM; El-Sawalhi MM; Shaheen AA
    Mol Neurobiol; 2017 Jul; 54(5):3219-3229. PubMed ID: 27067589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination.
    Zhang Y; Zhang H; Wang L; Jiang W; Xu H; Xiao L; Bi X; Wang J; Zhu S; Zhang R; He J; Tan Q; Zhang D; Kong J; Li XM
    Schizophr Res; 2012 Jun; 138(1):8-17. PubMed ID: 22555017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bee Venom-Derived BBB Shuttle and its Correlation with Oligodendrocyte Proliferation Markers in Mice Model of Multiple Sclerosis.
    Danesh-Seta T; Emami F; Nasr-Esfahani MH; Ghaedi K; Aliomrani M
    Neurotox Res; 2021 Aug; 39(4):1181-1188. PubMed ID: 33871814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation and acceleration of intrinsic myelin repair.
    Sanadgol N; Golab F; Mostafaie A; Mehdizadeh M; Khalseh R; Mahmoudi M; Abdollahi M; Vakilzadeh G; Taghizadeh G; Sharifzadeh M
    Toxicol Appl Pharmacol; 2018 Mar; 342():86-98. PubMed ID: 29407366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
    Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S
    PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
    Tanaka T; Murakami K; Bando Y; Yoshida S
    J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis.
    Abdi M; Pasbakhsh P; Shabani M; Nekoonam S; Sadeghi A; Fathi F; Abouzaripour M; Mohamed W; Zibara K; Kashani IR; Zendedel A
    Neurotox Res; 2021 Dec; 39(6):1732-1746. PubMed ID: 34570348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives.
    Gharagozloo M; Galleguillos D; Jank L; Sotirchos ES; Smith MD; Garton T; Kumar S; Hussein O; Potluri S; Taylor M; Siu C; Mace JW; Dawson T; Dawson VL; Lee S; Calabresi PA
    Neurotherapeutics; 2023 Jul; 20(4):1229-1240. PubMed ID: 37296356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation.
    Sanadgol N; Golab F; Askari H; Moradi F; Ajdary M; Mehdizadeh M
    Metab Brain Dis; 2018 Feb; 33(1):27-37. PubMed ID: 29022246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icariin enhances remyelination process after acute demyelination induced by cuprizone exposure.
    Zhang Y; Yin L; Zheng N; Zhang L; Liu J; Liang W; Wang Q
    Brain Res Bull; 2017 Apr; 130():180-187. PubMed ID: 28161197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
    Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
    J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.